Archive: 22/12/2017

Researchers report a new target to treat prostate cancer

The drug Gefitinib is used to treat breast, lung, and other cancers by inhibiting epidermal growth factor receptor (EGFR) signaling, but it has only a limited effect on prostate cancer. EGFR, present on the cell membrane, ...

page 3 from 5